Saturday, 28 January 2012
CASE 384 - Roche
Roche Diagnostics is a diagnostic division of Hoffmann-La Roche which manufactures equipment and reagents for research and medical diagnostic applications. Internally, it is organized into five major business areas: Roche Applied Science, Roche Professional Diagnostics, Roche Diabetes Care, Roche Molecular Diagnostics and Roche Tissue Diagnostics (Ventana).
All business areas except Roche Applied Science focus on health care applications, targeting either physicians, hospitals and clinics, or consumers. Applied Science targets research settings in academia and pharmaceutical and biotechnology industries.
The founder of Roche, Fritz Hoffmann-La Roche, was a pioneering entrepreneur who was convinced that the future belonged to branded pharmaceutical products. He was among the first to recognise that the industrial manufacture of standardised medicines would be a major advance in the fight against disease.
This led him to found F. Hoffmann-La Roche & Co. on October 1, 1896. From the very beginning, Fritz Hoffmann attached great importance to product information as the link between the pharmaceutical manufacturer and doctors, pharmacists and patients. Shortly after the foundation of the company in Basel, Switzerland, affiliates were opened in Germany, Italy, France, the US, Great Britain and Russia.
Since then, Roche has grown into one of the world's leading healthcare companies and one of the most important in Europe.
Roche Professional Diagnostics’ products support clinical decision making in a wide variety of indication fields, including oncology, virology, cardiovascular, inflammatory and infectious diseases.